We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,555 results
  1. Development of an effective single-chain variable fragment recognizing a novel epitope in the hepatitis C virus E2 protein that restricts virus entry into hepatocytes

    Previously, we reported a neutralizing monoclonal antibody, A8A11, raised against a novel conserved epitope within the hepatitis C virus (HCV) E2...

    Soma Das, Padmanava Behera, ... Anjali A Karande in Archives of Virology
    Article 29 April 2024
  2. Potential of an anti-bevacizumab idiotype scFv DNA-based immunization to elicit VEGF-binding antibody response

    Anti-idiotype antibodies have been considered for vaccination approaches against different diseases, including cancers. Based on that, we previously...

    Tábata Almeida Silva, Rodrigo Barbosa Aguiar, ... Jane Zveiter Moraes in Gene Therapy
    Article 08 December 2022
  3. A comprehensive comparison between camelid nanobodies and single chain variable fragments

    By the emergence of recombinant DNA technology, many antibody fragments have been developed devoid of undesired properties of natural...

    Yasaman Asaadi, Fatemeh Fazlollahi Jouneghani, ... Fatemeh Rahbarizadeh in Biomarker Research
    Article Open access 04 December 2021
  4. Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer

    Background

    Chimeric antigen receptor (CAR) -T cell therapy is an efficient therapeutic strategy for specific hematologic malignancies. However,...

    Jian Chen, Tianchuan Zhu, ... ** Huang in Molecular Cancer
    Article Open access 10 August 2023
  5. Isolation of single-chain variable fragment (scFv) antibodies for detection of Chickpea chlorotic dwarf virus (CpCDV) by phage display

    Chickpea chlorotic dwarf virus (CpCDV, genus Mastrevirus ), has a wide host range and geographic distribution in many parts of the world, and it is...

    Hamideh Raeisi, Mohammad Reza Safarnejad, ... Yalda Sokhansanj in Archives of Virology
    Article 24 September 2020
  6. An oncolytic herpes simplex virus type 1 strain expressing a single-chain variable region antibody fragment against PD-1 and a PI3K inhibitor synergize to elicit antitumor immunity in ovarian cancer

    Due to recurrence and resistance to chemotherapy, the current standard therapeutics are not fully effective against ovarian cancer. Therefore, we...

    Shanying Huang, Haiyan Hu, ... Weiwei Zeng in Archives of Virology
    Article 31 March 2023
  7. A structure and knowledge-based combinatorial approach to engineering universal scFv antibodies against influenza M2 protein

    Background

    The influenza virus enters the host via hemagglutinin protein binding to cell surface sialic acid. Receptor-mediated endocytosis is...

    Ujjwal Kumar, Priya Goyal, ... Dinakar M. Salunke in Journal of Biomedical Science
    Article Open access 25 July 2023
  8. Cell-penetrating porcine single-chain antibodies (transbodies) against nonstructural protein 1β (NSP1β) of porcine reproductive and respiratory syndrome virus inhibit virus replication

    Porcine reproductive and respiratory syndrome virus (PRRSV) causes porcine reproductive and respiratory syndrome (PRRS) worldwide, especially in...

    K. Thueng-in, S. Theerawatanasirikul, ... W. Chaicumpa in Archives of Virology
    Article 07 April 2023
  9. Dual Efficacy of a Catalytic Anti-Oligomeric Aβ42 scFv Antibody in Clearing Aβ42 Aggregates and Reducing Aβ Burden in the Brains of Alzheimer’s Disease Mice

    One of the primary pathological mechanisms underlying Alzheimer’s disease (AD) is the deposition of amyloid β-protein (Aβ42) aggregates in the brain....

    Chuli Song, He Li, ... Yingjiu Zhang in Molecular Neurobiology
    Article 16 June 2023
  10. Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with 89Zirconium oxine for PET imaging

    Background

    Chimeric antigen receptor (CAR) T cell therapy is an exciting cell-based cancer immunotherapy. Unfortunately, CAR-T cell therapy is...

    Pamela Leland, Dhiraj Kumar, ... Bharat H. Joshi in Journal of Translational Medicine
    Article Open access 07 June 2023
  11. Inhibitory Effect of Tetramerized Single-Chain Variable Fragment of Anti-Cyclic Citrullinated Peptide Antibodies on the Proliferation, Activation, and Secretion of Cytokines of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis In Vitro Co-Culture System

    Tetramerized single-chain variable fragment (ScFv) of anti-cyclic citrullinated peptide (TeAb-CCP) is a constructed tetramerized ScFv of anti-cyclic...

    **g Wang, Ning Tie, ... **xiong Kang in Inflammation
    Article 01 August 2020
  12. Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC

    Background

    Chimeric antigen receptor (CAR)-T cells can induce powerful immune responses in patients with hematological malignancies but have had...

    Micaela Harrasser, Satyen Harish Gohil, ... Amit Chunilal Nathwani in Breast Cancer Research
    Article Open access 03 June 2022
  13. Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH

    Background

    Immunotoxins are antibody-toxin conjugates that bind to surface antigens and exert effective cytotoxic activity after internalization into...

    **aoyu Liu, Qingqing Tan, ... Wei Gao in Journal of Translational Medicine
    Article Open access 25 August 2023
  14. The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment

    In this study, we investigated CD70 as a promising target for renal cell carcinoma (RCC) therapy and developed a potent chimeric antigen receptor T...

    Qinghui **ong, Haiying Wang, ... Pengfei Jiang in Journal of Translational Medicine
    Article Open access 18 April 2024
  15. Therapeutic Human Monoclonal Antibodies

    Since the discovery of obtaining mouse monoclonal antibodies (MAbs) in 1975 by somatic cell hybridization, there have been rapid developments to use...
    Satish Kumar Gupta, Piyush Chaudhary in Biomedical Translational Research
    Chapter 2022
  16. Nanobody-based CAR-T cells for cancer immunotherapy

    Chimeric antigen receptor T-cell (CAR-T) therapy is the result of combining genetic engineering-based cancer immunotherapy with adoptive cell therapy...

    Pouya Safarzadeh Kozani, Abdolhossein Naseri, ... Pooria Safarzadeh Kozani in Biomarker Research
    Article Open access 25 April 2022
  17. Haemagglutinin antigen selectively targeted to chicken CD83 overcomes interference from maternally derived antibodies in chickens

    Maternally derived antibodies (MDAs) are important for protecting chickens against pathogens in the neonatal stage however, they often interfere with...

    Angita Shrestha, Rick Meeuws, ... Munir Iqbal in npj Vaccines
    Article Open access 03 March 2022
  18. An auto-antibody identified from phenotypic directed screening platform shows host immunity against EV-A71 infection

    Background

    Enterovirus A71 (EV-A71) is a neurotropic virus which may cause severe neural complications, especially in infants and children. The...

    Yu-Wei Cheng, Yung-Chun Chuang, ... Jen-Ren Wang in Journal of Biomedical Science
    Article Open access 08 February 2022
Did you find what you were looking for? Share feedback.